May 11, 2017


On April 27 the scientific and educational conference "School of the Comorbid Patient" was held. At the event, scientists and doctors cardiologists, immunologists, therapists, gerontologists made speeches. The program included discussion of anticoagulant therapy and risks of developing cardiovascular diseases in comorbid patients. More than 60 doctors took part in the conference. The event was organized with the support of Pfizer.